Trxade Health Inc. (NASDAQ: MEDS) is a health service IT company that is on a mission to enable independent pharmacies to operate
Trxade Group Inc.
-(MEDS)
XNAS:MEDS
TRxADE Health Inc (MEDS) Q3 2022 Earnings Call Transcript
TRxADE Health Inc (NASDAQ:MEDS) Q3 2022 Earnings Call dated Nov. 07, 2022. Corporate Participants: Janet Huffman -- Chief Financial Officer Suren Ajjarapu -- Founder, Chairman and
Earnings: Trxade Health (MEDS) reports 6% drop in Q3 revenue; loss narrows
Trxade Health Inc (NASDAQ: MEDS), a leading health service IT company, reported a modest decline in its third-quarter revenues. Meanwhile, the company's
Trxade Health Inc. (NASDAQ: MEDS) Q3 2022 Research Summary
Trxade Health Inc. (NASDAQ: MEDS) is an integrated drug delivery platform that offers a digitalized retail pharmacy experience to independent pharmacies, allowing
Trxade will focus more on core biz, connect with POS systems: CEO Suren Ajjarapu
Trxade Health Inc. (NASDAQ: MEDS) has been on a mission to digitalize the retail pharmacy experience by providing a platform for independent
MEDS Earnings: Trxade Health Q2 revenues surge 73% amid continued user growth
Trxade Health Inc (NASDAQ: MEDS), a leading health service IT company, reported a sharp increase in its second-quarter 2022 revenues. The top
TRxADE HEALTH, Inc. (MEDS) Q2 2022 Earnings Call Transcript
TRxADE HEALTH, Inc. (NASDAQ: MEDS) Q2 2022 earnings call dated Jul. 25, 2022 Corporate Participants: Janet Huffman -- Chief Financial Officer Suren Ajjarapu -- Chief Executive
Trxade (MEDS) is increasing the breadth of product offerings: CEO Suren Ajjarapu
Trxade Health Inc. (NASDAQ: MEDS) is an online pharmaceutical marketplace that provides a platform for independent pharmacies to operate more efficiently. The
TRxADE HEALTH Inc. (MEDS) Q1 2022 Earnings Call Transcript
TRxADE HEALTH Inc. (NASDAQ: MEDS) Q1 2022 earnings call dated May. 09, 2022 Corporate Participants: Janet Huffman -- Chief Financial Officer Suren Ajjarapu -- Founder, Chairman
Trxade Health (MEDS) reports 6% growth in Q1 revenue; loss widens
Pharmaceutical services company Trxade Health Inc (NASDAQ: MEDS) Monday reported a wider net loss for the first quarter of 2022 despite a 6%
Trxade Health Inc. (NASDAQ: MEDS) Q1 2022 Research Summary
Trxade Health Inc. (NASDAQ: MEDS) is a health service IT company focused on optimizing drug procurement and patient engagement. It helps independent
Trxade will stay focused on traditional technology platform for margin growth: CEO Suren Ajjarapu
[caption id="attachment_135351" align="alignnone" width="1280"] Image: iStock[/caption] Can you briefly talk about your business model and the value you add to the market?
TRxADE HEALTH, Inc. (MEDS) Q4 2021 Earnings Call Transcript
TRxADE HEALTH, Inc. (NASDAQ: MEDS) Q4 2021 earnings call dated Mar. 28, 2022 Corporate Participants: Howard Doss -- Chief Financial Officer Suren Ajjarapu -- Chief Executive Officer
Trxade Health (MEDS) reports 20% growth in Q4 revenue; results beat estimates
Trxade Health Inc (NASDAQ: MEDS) Monday reported a narrower net loss for the fourth quarter of 2021 as the pharmaceutical services company's revenues
Trxade Health Inc. (NASDAQ: MEDS) Q4 2021 Research Summary
Trxade Health Inc. (NASDAQ: MEDS) is a healthcare service technology platform that mainly serves the secondary pharmaceutical supply chain, offering a web-based
Trxade CEO Suren Ajjarapu: Will see the impact of GPO program by Q3 next year
Image: iStock Give us a quick overview of the company. Trxade is a market platform that caters to the independent pharmacies that
Trxade Health beats on Q3 revenue estimate
Trxade Health Inc (NASDAQ: MEDS) on Monday posted third-quarter revenues of $2.6 million, down year-over-over as a result of non-recurring PPE sales.
TRxADE HEALTH, Inc. (MEDS) Q3 2021 Earnings Call Transcript
TRxADE HEALTH, Inc. (NASDAQ: MEDS) Q3 2021 earnings call dated Oct. 25, 2021 Corporate Participants: Howard Doss -- Chief Financial Officer Suren Ajjarapu -- Chief Executive
Trxade Health Inc. (NASDAQ: MEDS) Q3 2021 Research Summary
It is estimated that the North American e-Pharmacy market would grow at a compound annual rate of 14.8% through 2025. In the
Trxade CEO: Will see consistent margins ahead
Shares of Trxade Health Inc (NASDAQ: MEDS) took a beating post the second-quarter results earlier this week as the provider of integrated
TRxADE HEALTH, Inc. (MEDS) Q2 2021 Earnings Call Transcript
TRxADE HEALTH, Inc. (NASDAQ: MEDS) Q2 2021 earnings call dated Jul. 26, 2021 Corporate Participants: Howard Doss -- Chief Financial Officer Suren Ajjarapu -- Chief Executive